A centrally acting medicine used for selected high blood pressure treatment.
Profile scope: Methyldopa. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Sleepiness, dry mouth, headache, gastrointestinal upset and swelling may occur.
Serious risks and warning signs
Serious liver injury and immune-mediated hemolytic anemia are important concerns. Unexplained fever, jaundice, marked tiredness, pallor or breathlessness needs prompt assessment. Laboratory monitoring can detect problems before symptoms become severe.
A question for your healthcare team
What liver and blood-count checks are planned, and which symptoms require advice before another dose?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
- NIH / MedlinePlus: full medicine information
- NIH DailyMed: methyldopa liver and hemolytic-anemia precautions
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.